Skip to content
Disclosery

CITADEL ADVISORS LLC: IMRX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CITADEL ADVISORS LLC on IMRX, newest first. How the timeline and the estimate are built.

CITADEL ADVISORS LLC held 386,411 IMRX shares at 2026-06-30 per its 13F-HR/A filed 2026-09-02.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F/A 386,411 shares
    Change vs previous 13F -60,867 shares

    <0.01% of the 13F portfolio, value $1,928,191.

    13F-HR/A 0001104659-26-104387 filed by CITADEL ADVISORS LLC
    Accepted , ingested

  2. period ended2026-03-31
    13F 447,278 shares
    Change vs previous 13F +356,819 shares

    <0.01% of the 13F portfolio, value $2,357,155.

    13F-HR 0001104659-26-062477 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 90,459 shares
    Change vs previous 13F -852,685 shares

    <0.01% of the 13F portfolio, value $595,221.

    13F-HR 0001104659-26-016408 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 943,144 shares
    Change vs previous 13F +943,144 shares

    0.01% of the 13F portfolio, value $6,602,008.

    13F-HR 0001104659-25-112514 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 0 shares
    Change vs previous 13F not available

    13F-HR 0000950123-24-011767 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.